|

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

RECRUITINGN/ASponsored by Erkan Gol
Actively Recruiting
PhaseN/A
SponsorErkan Gol
Started2026-03-02
Est. completion2027-02
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07431788

Summary

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women aged ≥18 years
* Planned total abdominal hysterectomy for benign indications
* Sexually active within the last 4 weeks
* Able to complete the Female Sexual Function Index (FSFI) questionnaire
* Provided written informed consent

Exclusion Criteria:

* Gynecologic malignancy
* Major additional pelvic reconstructive surgery
* Severe psychiatric or neurologic disorder
* Inability to complete follow-up assessments

Conditions4

Adenomyoma of UterusCancerLeiomyoma (Uterine Fibroids)Uterine Bleeding

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.